Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1

KAI-CHANG ZHU(Shandong Provincial Hospital), Jiaju Lv(Shandong University)
Oncology Letters
August 18, 2015
Cited by 30


Related Papers

No related papers found

Powered by citation graph analysis